ClinicalTrials.Veeva

Menu

Salivary Cystatin S Levels in a Group of Egyptian Children

Cairo University (CU) logo

Cairo University (CU)

Status

Active, not recruiting

Conditions

Early Childhood Caries

Treatments

Biological: Measurement of salivary cystatin S protein levels in saliva

Study type

Observational

Funder types

Other

Identifiers

NCT05716867
PEDO 1-2-1

Details and patient eligibility

About

Aim of the study

  1. Measuring the levels of salivary cystatin S protein and salivary buffering capacity to determine their relation to early childhood caries.
  2. Predection of early childhood caries by using salivary cystatin S levels with demographic, clinical and nutrition habits characteristics of the participants.

Enrollment

30 estimated patients

Sex

All

Ages

36 to 71 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Medically free children aged 36 to 71 months with one or more decayed (noncavitated or cavitated lesions), missing, or filled teeth due to caries in any primary tooth(cases).
  • Medically free children aged 36 to 71 months with no decayed, missing, or filled teeth due to caries in any primary tooth(controls).

Exclusion criteria

  • Children receiving antibiotic therapy within three month and fluoride prophylaxis within one year.
  • Parents who will refuse to participate or refuse to sign the informed consent.
  • Children who will not agree or cooperate with participation.

Trial design

30 participants in 2 patient groups

Children with early childhood caries aged between 36-71 month
Treatment:
Biological: Measurement of salivary cystatin S protein levels in saliva
Caries free children aged between 36-71 month
Treatment:
Biological: Measurement of salivary cystatin S protein levels in saliva

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems